This study was performed to compare the mortality associated with carbapenem-resistant
Acinetobacter baumannii (CRAB) and carbapenem-sensitive A. baumannii (CSAB) …

BACKGROUND: Risk factors and outcome in patients who acquire nosocomial infections
due to carbapenem-resistant Acinetobacter baumannii (CRAB) are rarely investigated …

This study assessed risk factors for 30-day mortality in 66 patients with carbapenem-
resistant Acinetobacter baumannii (CRAB) infection or colonization during an outbreak in an …

This study investigated predictors associated with 14-day mortality, and focused especially
on the impact of appropriate antimicrobial treatment among patients with carbapenem …

Background: The incidence density, the risk factors and the attributable mortality of
carbapenem-resistant Acinetobacter baumannii (CR-AB) infections are rarely investigated …

BACKGROUND: It is still controversial whether carbapenem-resistant Acinetobacter
baumannii (CRAB) is an independent risk factor for mortality. This study aimed to determine …

Background There has been an increasing incidence of carbapenem-resistant
Acinetobacter baumannii (CRAB) infections in recent years. The objective of this study was …

Objective: To evaluate treatment outcomes in patients with carbapenem-resistant
Acinetobacter baumannii (CRAB) nosocomial infections treated with antimicrobial agent …

Purpose. This study was aimed to identify the determinants of in‐hospital mortality in
Acinetobacter baumannii (A. baumannii) bacteremia and to assess impact of carbapenem …

To assess the risk factors for carbapenem-resistant Acinetobacter baumannii (CRAB)
bacteremia and for 30-day mortality in patients with CRAB bacteremia in the intensive care …